# Safety and Efficacy of Drug Combinations Against Schistosomiasis

> **NCT01050374** · NA · COMPLETED · sponsor: **DBL -Institute for Health Research and Development** · enrollment: 650 (estimated)

## Conditions studied

- Parasitic Diseases

## Interventions

- **DRUG:** albendazole + praziquantel
- **DRUG:** mebendazole + praziquantel

## Key facts

- **NCT ID:** NCT01050374
- **Lead sponsor:** DBL -Institute for Health Research and Development
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 650 (ESTIMATED)
- **Last updated:** 2010-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050374, "Safety and Efficacy of Drug Combinations Against Schistosomiasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01050374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*